Upregulation of the CD40-CD40 ligand system in pre-eclampsia

International Journal of Gynecology and Obstetrics

Volumn 105, Issue 3, 2009, Pages 257-260

  Lukanov, Tzvetan Hristoforov ^a,b   Bojinova, Svetla Ivanova ^a   Emin, Alkan Levha ^b   Veleva, Galina Lubomirova ^a   Popova, Vanya Slavcheva ^a   Konova, Emiliana Ilieva ^b  

^a University Hospital   (Bulgaria)

^b MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

CD40; CD40 ligand; Flow cytometry; Inflammation; Pre eclampsia

Indexed keywords

CD40 LIGAND;

ADULT; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MONOCYTE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; THROMBOCYTE; UPREGULATION;

EID: 67349222914     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.01.034     Document Type: Article

References (25)

1. Roberts J.M., and Gammill H.S. Preeclampsia: recent insights. Hypertension 46 6 (2005) 1243-1249
2. Matthiesen L., Berg G., Ernerudh J., Ekerfelt C., Jonsson Y., and Sharma S. Immunology of preeclampsia. In: Markert U.R. (Ed). Immunology of Pregnancy. Chem Immunol Allergy vol. 89 (2005), Karger, Basel 49-61
3. LaMarca B.D., Gilbert J., and Granger J.P. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 51 4 (2008) 982-988
4. Janes S.L., Kyle P.M., Redman C., and Goodall A.H. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb Haemost 74 4 (1995) 1059-1063
5. Holthe M.R., Staff A.C., Berge L.N., and Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol 190 4 (2004) 1128-1134
6. Konijnenberg A., van der Post J.A., Mol B.W., Schaap M.C., Lazarov R., Bleker O.P., et al. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 177 2 (1997) 434-442
7. Von Hundelshausen P., and Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100 1 (2007) 27-40
8. Freedman J.E. CD40-CD40L and platelet function: beyond hemostasis. Circ Res 92 9 (2003) 944-946
9. Inwald D.P., McDowall A., Peters M.J., Callard R.E., and Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92 9 (2003) 1041-1048
10. Henn V., Slupsky J.R., Gräfe M., Anagnostopoulos I., Förster R., Müller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 6667 (1998) 591-594
11. Wagner D.D., and Burger P.C. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23 12 (2003) 2131-2137
12. Lutgens E., Gorelik L., Daemen M.J., de Muinck E.D., Grewal I.S., Koteliansky V.E., et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 5 11 (1999) 1313-1316
13. Henn V., Steinbach S., Büchner K., Presek P., and Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98 4 (2001) 1047-1054
14. Laskowska M., Laskowska K., Leszczyńska-Gorzelak B., and Oleszczuk J. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation. Gynecol Obstet Invest 64 1 (2007) 8-13
15. Alacacioglu I., Ozcan M.A., Piskin O., Yuksel F., Alacacioglu A., Demirkan F., et al. Increased concentration of soluble CD40 ligand in preeclampsia. Clin Appl Thromb Hemost 13 2 (2007) 201-205
16. Oron G., Ben-Haroush A., Hod M., Orvieto R., and Bar J. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia. Obstet Gynecol 107 4 (2006) 896-900
17. Wagner L.K. Diagnosis and management of preeclampsia. Am Fam Physician 70 12 (2004) 2317-2324
18. Garlichs C.D., John S., Schmeisser A., Eskafi S., Stumpf C., Karl M., et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104 20 (2001) 2395-2400
19. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger III A.L., and Furman M.I. Evaluation of platelet function by flow cytometry. Methods 21 3 (2000) 259-270
20. Andre P., Nannizzi-Alaimo L., Prasad S.K., and Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106 8 (2002) 896-899
21. da Costa Martins P., García-Vallejo J.J., van Thienen J.V., Fernandez-Borja M., van Gils J.M., Beckers C., et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol 27 5 (2007) 1023-1029
22. Luppi P., and DeLoia J.A. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 118 2-3 (2006) 268-275
23. Melter M., Reinders M.E., Sho M., Pal S., Geehan C., Denton M.D., et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96 12 (2000) 3801-3808
24. Ustun Y., Engin-Ustan Y., and Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstes Gynaecol Reprod Bio 121 2 (2005) 154-158
25. Freedman J.E., and Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 105 18 (2002) 2130-2132